Literature DB >> 16367807

A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.

Min Guo1, Sharon D Ricardo, James A Deane, Ming Shi, Luise Cullen-McEwen, John F Bertram.   

Abstract

In diabetic nephropathy, glomerular hypertrophy is evident early in response to hyperglycaemia. Alterations of capillary length and vascular remodelling that may contribute to glomerular hypertrophy and the subsequent development of glomerulosclerosis remain unclear. The present study used the db/db mouse model of Type 2 diabetes to examine the glomerular microvascular changes apparent with long-term diabetic complications. Unbiased stereological methods and high-resolution light microscopy were used to estimate glomerular volume, and glomerular capillary dimensions including length and surface area in 7-month-old db/db diabetic mice and age-matched db/m control mice. The db/db diabetic mice showed significant glomerular hypertrophy, corresponding with elevated blood glucose levels, and increased body weight and kidney weight, compared with db/m control mice. Glomerular enlargement in db/db mice was associated with increases in the surface area (5.387 +/- 0.466 x 10(4) microm2 vs. 2.610 +/- 0.287 x 10(4) microm2; P < 0.0005) and length (0.3343 +/- 0.022 x 10(4) microm vs. 0.1549 +/- 0.017 x 10(4) microm; P < 0.0001) of capillaries per glomerulus, compared with non-diabetic mice. Stereological assessment at the electron microscopic level revealed increased glomerular volume density of mesangial cells and mesangial matrix, and thickening of the glomerular basement membrane in db/db mice. These results demonstrate that glomerular hypertrophy evident in advanced diabetic nephropathy in this model is associated with increased length and surface area of glomerular capillaries. The contribution of angiogenesis and vasculogenesis to the glomerular microvascular alterations in response to hyperglycaemia remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16367807      PMCID: PMC1571575          DOI: 10.1111/j.1469-7580.2005.00492.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  39 in total

Review 1.  Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development.

Authors:  A S Woolf; H T Yuan
Journal:  Pediatr Nephrol       Date:  2001-02       Impact factor: 3.714

2.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.

Authors:  T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

3.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

4.  Glomerular structure in lithium-induced chronic renal failure in rats.

Authors:  G Min; S Christensen; N Marcussen; R Osterby
Journal:  APMIS       Date:  2000-10       Impact factor: 3.205

5.  Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.

Authors:  M E Cooper; D Vranes; S Youssef; S A Stacker; A J Cox; B Rizkalla; D J Casley; L A Bach; D J Kelly; R E Gilbert
Journal:  Diabetes       Date:  1999-11       Impact factor: 9.461

6.  Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.

Authors:  An S DE Vriese; Ronald G Tilton; Marlies Elger; Clifford C Stephan; Wilhelm Kriz; Norbert H Lameire
Journal:  J Am Soc Nephrol       Date:  2001-05       Impact factor: 10.121

7.  On glomerular structural alterations in type-1 diabetes. Companions of early diabetic glomerulopathy.

Authors:  R Osterby; H J Bangstad; G Nyberg; S Rudberg
Journal:  Virchows Arch       Date:  2001-02       Impact factor: 4.064

8.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Authors:  F N Ziyadeh; B B Hoffman; D C Han; M C Iglesias-De La Cruz; S W Hong; M Isono; S Chen; T A McGowan; K Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

9.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Authors:  D Koya; M Haneda; H Nakagawa; K Isshiki; H Sato; S Maeda; T Sugimoto; H Yasuda; A Kashiwagi; D K Ways; G L King; R Kikkawa
Journal:  FASEB J       Date:  2000-03       Impact factor: 5.191

10.  Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes.

Authors:  P Wei; P H Lane; J T Lane; B J Padanilam; S C Sansom
Journal:  Diabetologia       Date:  2004-08-27       Impact factor: 10.122

View more
  37 in total

Review 1.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

2.  Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident Cells.

Authors:  Victor G Puelles; Rebecca N Douglas-Denton; Luise A Cullen-McEwen; Jinhua Li; Michael D Hughson; Wendy E Hoy; Peter G Kerr; John F Bertram
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

3.  Preterm birth and ventilation decrease surface density of glomerular capillaries in lambs, regardless of postnatal respiratory support mode.

Authors:  Eveline Staub; Mar Janna Dahl; Calan Yost; Sydney Bowen; Toshio Aoki; Adam Blair; Zhengming Wang; Donald M Null; Bradley A Yoder; Kurt H Albertine
Journal:  Pediatr Res       Date:  2017-01-06       Impact factor: 3.756

4.  LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis.

Authors:  Quan Hong; Lu Zhang; Jia Fu; Divya A Verghese; Kinsuk Chauhan; Girish N Nadkarni; Zhengzhe Li; Wenjun Ju; Matthias Kretzler; Guang-Yan Cai; Xiang-Mei Chen; Vivette D D'Agati; Steven G Coca; Detlef Schlondorff; John C He; Kyung Lee
Journal:  J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 10.121

5.  eNOS deficiency predisposes podocytes to injury in diabetes.

Authors:  Darren A Yuen; Bailey E Stead; Yanling Zhang; Kathryn E White; M Golam Kabir; Kerri Thai; Suzanne L Advani; Kim A Connelly; Tomoko Takano; Lei Zhu; Alison J Cox; Darren J Kelly; Ian W Gibson; Takamune Takahashi; Raymond C Harris; Andrew Advani
Journal:  J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 10.121

6.  Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor β2 Agonist.

Authors:  Steven E Trasino; Xiao-Han Tang; Maria M Shevchuk; Mary E Choi; Lorraine J Gudas
Journal:  J Pharmacol Exp Ther       Date:  2018-07-27       Impact factor: 4.030

Review 7.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

8.  Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet.

Authors:  Sarah F Knight; Jeffrey E Quigley; Jianghe Yuan; Siddhartha S Roy; Ahmed Elmarakby; John D Imig
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

9.  Abnormal angiogenesis in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Tomoki Kosugi; Masakazu Haneda; Christopher J Rivard; David A Long
Journal:  Diabetes       Date:  2009-07       Impact factor: 9.461

10.  Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

Authors:  Tatsuyo Nasu; Yohei Maeshima; Masaru Kinomura; Kumiko Hirokoshi-Kawahara; Katsuyuki Tanabe; Hitoshi Sugiyama; Hikaru Sonoda; Yasufumi Sato; Hirofumi Makino
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.